INTRODUCTION
Photoaffinity labelling techniques, which have been useful in molecular studies of receptor binding site polypeptides, have been applied recently to the study of nucleoside transporter polypeptides. In animal cells, this transport mechanism mediates the passage of a diverse group of nucleosides across the plasma membrane. NBMPR, a potent inhibitor of nucleoside transport in some cells, is bound tightly at specific membrane sites which are on, or associated with, transporter polypeptides. Upon exposure to u.v. light, site-bound NBMPR becomes covalently bound to a transporter polypeptide, allowing identification (on electrophoretograms) in human erythrocyte membranes , in a plasma membrane-enriched fraction from S49 mouse lymphoma cells , in membranecontaining preparations from rat and guinea pig lung (Shi et al., 1984) and liver , and in crude membrane preparations from guinea pig heart (Kwan & Jarvis, 1984 ) and brain (Jarvis & Ng, 1985) .
This report describes the electrophoretic identification of an NBMPR-binding polypeptide in membranes from a line of cultured Novikoff rat hepatoma cells. The nucleoside transport mechanism in Novikoff cells is of low sensitivity to NBMPR, requiring micromolar concentrations of the inhibitor to effect substantial inhibition of nucleoside transport (Wohlhueter et al., 1978; Plagemann & Wohlhueter, 1984) , whereas nanomolar concentrations of the inhibitor block nucleoside transport in erythrocytes and cultured S49 mouse lymphoma cells (Cass et al., 1974; Plagemann & Wohlhueter, 1984) and saturate the high affinity transporter sites at which the inhibitor is bound on the latter cells (Cass et al., 1974 . Unlike some Novikoff cell lines (e.g. the NIS1-67 wild type; Plagemann & Wohlhueter, 1980) , the Novikoff UA line used in the present study has binding sites for NBMPR. The nucleoside transporter of these cells differs from that of Walker 256 rat carcinosarcoma cells in that the latter cells not only have a nucleoside transport system with low sensitivity to NBMPR (Paterson et al., 1983a; Belt & Noel, 1985) , but also lack NBMPR binding sites (Paterson et al., 1983a (Cass & Au-Yeung, 1976; Paterson et al., 1983a) .
Nucleoside transport measurements
To determine the NBMPR sensitivity of cellular nucleoside transport systems, cells [(4-8) (Harley et al., 1982) at a protein concentration of 14-16 mg/ml by using a Dounce homogenizer, and stored in a liquid-N2 refrigerator. The membrane fraction from 109 cells contained about 25 mg of protein, or about 12% of total cell protein. Protein was determined by a modification (Peterson, 1977) of the method of Lowry et al. (1951) , using bovine serum albumin as a standard.
Equilibrium binding experiments
Portions of the membrane-containing preparation (20 1l, 300 ,ug of protein) were added to 1.0 ml of 50 mM-Tris/HCl (pH 7.4 at 22 C) containing graded concentrations of [3H]NBMPR (0.04-4 nM) in the presence or absence of NBTGR (10 /SM), the former condition providing determinations of non-specific binding. [NBTGR is a very potent inhibitor of nucleoside transport that is tightly bound and competes with NBMPR at the high-affinity, transporter-associated binding sites (Paterson et al., 1983b) .] In some experiments, other substances were included as inhibitors of NBMPR binding. After incubation of the suspensions at 22°C for 30 min, the crude membranes were collected onto Whatman GF/C glass fibre filters (prewashed with 5 ml ofice-cold Tris buffer). The filters were washed twice with 5 ml portions of ice-cold buffer and incubated in a Triton-based liquid-scintillation cocktail (Pande, 1976) for at least 2 h before assay of radioactivity. Equilibrium concentrations of free [3H]NBMPR were determined by subtraction of bound radioactivity from the total determined for each incubation suspension. Specific binding was determined as the difference between binding in the absence (total binding) and in the presence (non-specific binding) of 10 ,zM-NBTGR.
Photoaffinity labelling
Portions of the membrane-containing preparation (about 1.5 mg of protein) were incubated in 50 mmTris/HCl (pH 7.4 at 22 C) containing 50 nM-[3H]-NBMPR and 50 mM-dithiothreitol in a total volume of 200,ul. In some experiments, nucleoside permeants or other transport inhibitors were included to determine their effects on NBMPR binding. The suspensions were incubated for 15 min at 22°C, then chilled to 4°C and transferred to 1 mm light path quartz cuvettes. The cuvettes were kept chilled during a 1 min irradiation with u.v. light at a distance of 4 cm from the quartz cooling sleeve of a 450 W mercury-arc lamp (Canrad-Hanovia Inc., Newark, NJ, U.S.A.). The suspension was then diluted 75-fold in Tris buffer containing 10 ,sM-NBTGR and allowed to stand at room temperature for 20 min. The membrane fraction was recovered by centrifugation at 41000 g for 25 min and dissolved at room temperature in gel sample buffer [5% (w/v) SDS, 5 mM-Na2 EDTA, 10% (w/v) glycerol, 0.01 % Bromphenol Blue, 2 mMphenylmethanesulphonyl fluoride, 10 mM-dithiothreitol, and 20 mM-Tris/HCI (pH 8.0 at 22°C)].
Gel electrophoresis SDS/polyacrylamide-gel electrophoresis was performed in 1.5 mm thick acrylamide slab gels in the discontinuous buffer system of Laemmli (1970) according to the method of Thompson & Maddy (1982 
RESULTS

Inhibition of qdenosine transport by NBMPR
The effect of prior equilibration with NBMPR on adenosine transport in Novikoff UA cells is shown in Fig.  1 . Results of identical experiments with S49, L12 10, and Walker 256 cells were included for comparison. In S49 cells, the transport of adenosine was sensitive to NBMPR with an IC50 value (that concentration of NBMPR capable of reducing the rate of adenosine transport to 50% of the control value) of 2 nm, and inhibition of transport was virtually complete when cells were exposed to 100 nM-NBMPR. In contrast, both Walker 256 and Novikoff UA cells were relatively insensitive to NBMPR with 50% inhibition of transport resulting from exposure to NBMPR concentrations greater than 10 gM. These high IC50 values are in agreement with previous reports (Wohlhueter et al., 1979; Paterson et al., 1983a; Belt, 1983) NBMPR. The concentration-effect curve for NBMPR inhibition of adenosine transport in L1210 cells was biphasic with a broad plateau spanning the range from 10 to 1000 nM-NBMPR, indicating that these cells have two types of transport activity that differ in sensitivity to NBMPR (Belt, 1983 Interaction of these compounds with the nucleoside transport mechanism ofNovikoff cells has been described (Plagemann & Wohlhueter, 1980) . The double reciprocal plot in Fig. 3 50000-54000. Fig. 5 compares gel radioactivity profiles obtained with membrane preparations from S49 cells and NovikoffUA cells. These preparations were photolabelled separately and then subjected to electrophoretic analysis, each in separate lanes (Fig. Sa) in the same gel slab, or together in a third lane (Fig. Sb) . These Figures show that, in the mixed sample, two specifically labelled polypeptide bands were evident, and that the Mr values of these corresponded to those in the preparations from each cell line.
DISCUSSION
An NBMPR-binding polypeptide from a membraneenriched fraction ofNovikoffUA cells has been identified by covalent labelling with [3H]NBMPR. Although these cells have binding sites for NBMPR, nucleoside transport remains unaffected in the presence of site-saturating concentrations of the inhibitor. The apparent Mr of this polypeptide determined by SDS/polyacrylamide-gel electrophoresis was 72000-80000, a value that differs from those of transporter polypeptides in several other cell types (45000-66000), determined by the same photoaffinity labelling procedures. Identification of the NBMPR-photolabelled polypeptides as nucleoside transporter components has been based mainly on the concept that the high affinity membrane sites at which NBMPR is bound are part of the nucleoside transport mechanism. Evidence for this concept includes (a) the observed proportionality between binding site occupancy by NBMPR and fractional inhibition ofuridine transport by NBMPR in human erythrocytes (Cass et al., 1974), (b) instances of the joint presence of functional nucleoside transporters and of high affinity NBMPR binding sites in some cell types, or the joint absence of these properties in other cell types , (c) the proportionality between the nucleoside transport capacity (Vmax.) and the abundance ofthe high affinity binding sites in erythrocytes from various species Jarvis & Young, 1982) , and (d) the joint reconstitution of uridine transport activity by the incorporation into phospholipid vesicles of partially purified NBMPR-binding protein from human erythrocytes (Tse et al., 1985) .
While some types ofcells (notably erythrocytes and S49 cells) possess NBMPR-sensitive nucleoside transporters with sites that bind NBMPR with high affinity (as noted above), the existence of nucleoside transport mechanisms oflow sensitivity to NBMPR has been recognized in other cell types (for example, Novikoff UA and Walker 256 cells) in which substantial inhibition of transport occurs only in the presence of micromolar concentrations of NBMPR. Thus, while nucleoside permeation is mediated in cultured cells of two lines, the Walker 256 carcinosarcoma (Belt & Noel, 1985) and the Novikoff hepatoma NlS1-67 wild type (Plagemann & Wohlhueter, 1980) , cells of both lines lack sites that bind NBMPR with high affinity (Paterson et al., 1983a; Plagemann & Wohlhueter, 1984) . Other cell types (for example, L1210, HeLa and CHO cells) appear to possess nucleoside transporters of both low and high NBMPR sensitivity. The latter are apparent in the biphasic responses (inhibition) that are seen when cells are exposed to graded concentrations (from micromolar to nanomolar) ofNBMPR (Belt, 1983; Dahlig-Harley et al., 1981; Plagemann & Wohlhueter, 1984) . Sites on these cells that bind NBMPR with high affinity are likely associated with nucleoside transporters of high NBMPR sensitivity. The Novikoff UA cells used in this study present a further complication in that, while the nucleoside transport mechanism in these cells is of low NBMPR sensitivity, sites that bind NBMPR with high affinity are present.
The uncloned cell stock (Novikoff Nl S 1-67 wild type; Plagemann & Wohlhueter, 1984) , from which our Novikoff UA line was derived, evidently contains variants which synthesize polypeptides that bind NBMPR with high affinity (as in S49 cells and Vol. 236 erythrocytes). The presence of binding site variants in the uncloned Novikoff UA cell line has been shown (J. A. Belt, unpublished work) by the isolation of clones that (a) lack NBMPR binding sites, or (b) possess such sites at several different levels of cellular abundance. Covalent NBMPR labelling (W. P. Gati & A. R. P. Paterson, unpublished work) of a membrane-enriched preparation from one of the latter clones (in which cells had nine times as many binding sites as cells of the parental Novikoff UA line) with [3H]NBMPR resulted in identification of a polypeptide with an Mr similar to that found in membranes from Novikoff UA cells in this study (Figs. 4 and 5) .
Our identification of the NBMPR-binding polypeptide in Novikoff UA cells as a transporter polypeptide is supported by the observed blockade of NBMPR photolabelling in the presence of adenosine, uridine, and dipyridamole, substances that interact with the nucleoside transport mechanism in Novikoff cells (Plagemann & Wohlhueter, 1980) . The apparently competitive inhibition by uridine and dipyridamole of NBMPR binding to Novikoff UA membrane sites does not necessarily mean that these substances-interact at the nucleoside permeation site, as we have argued elsewhere (Koren et al., 1983; Jarvis et al., 1983) .
Although high affinity binding of NBMPR to the Novikoff UA polypeptide and inhibition by nucleoside permeants of this binding support the idea that this polypeptide is part of the transport mechanism, its role in nucleoside permeation remains unclear. The high Mr of the Novikoff UA NBMPR-binding polypeptide may be related to the low NBMPR sensitivity of nucleoside transport in these cells. Additional studies are required to determine whether this apparently distinctive molecular property restricts the transport inhibitory effects of bound NBMPR.
